Navigation Links
Funding to tackle hospital superbugs

A novel approach to treating infectious diseases is being developed by researchers at Cardiff University.

Superbugs such as MRSA (Methicillin Resistant Staphylococcus Aureus) are resistant to one of more conventional antibiotic and require new therapies to aid the treatment of infection.

A team in the School of Medicine's Institute of Nephrology has been awarded £800,000 by the Wellcome Trust to commercially develop a protein based therapeutic to help treat infectious diseases.

Professor Nicholas Topley said: "Infectious diseases are a significant problem and the number of new antibiotics entering the market is falling rapidly whilst antibiotic resistance is increasing. The funding from the Wellcome Trust will help bring the pioneering new approaches developed in the School of Medicine to the market."

Research into the development of novel proteins discovered by the team led by Professor Topley and Dr Simon Jones has already identified new pathways that enhance the bodies natural defence mechanisms to promote the clearance of infection. The new approach has been named "Resolution Therapeutics" by the Cardiff researchers.

It is hoped that research in the School of Medicine will lead to the development of other drugs that modify host responses with the view to resolving infection and reducing inflammation in diseases such as arthritis.


'"/>

Source:Cardiff University


Page: 1

Related biology news :

1. Funding and bureaucracy, not access to journals, are chief obstacles to scientific productivity
2. South Africa still debating how to tackle HIV/AIDS when 5 million are infected
3. Cancer cells suppress large regions of DNA by a reversible process that can be tackled
4. Smooth sailing: cruise ship virus tackled by UH, Baylor College of Medicine
5. Research project tackles regeneration gap
6. New antibacterials being developed to tackle MRSA superbug
7. New strategies to reduce hospital-aquired infections
8. Bacteria can survive for weeks on hospital surfaces
9. One in 14 men having a heart attack drive themselves to hospital
10. Minorities, uninsured less likely to receive care at high-volume hospitals
11. Controlling antibiotics and antibiotic resistance in hospitals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology: